Mannkind Corp cash flow statement
In fiscal 2025, Mannkind Corp's operations generated $18.3m of cash; it spent $4.6m on capital projects, leaving free cash flow of $13.7m.
Cash flow statement
| Fiscal year | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −149 | −124 | −120 | −129 | 4 | −57 | −78 | −65 | −38 | −88 | −28 | −62 | −81 | 34 | 43 | 18 | −8 |
| Depreciation and amortisation | 17 | 15 | 13 | 12 | 10 | 11 | 2 | 2 | 3 | 1 | 2 | 2 | 3 | 5 | 7 | 12 | 16 |
| Stock-based pay | 14 | 11 | 13 | 45 | 49 | 9 | 5 | 5 | 7 | 6 | 7 | 12 | 13 | 18 | 21 | 24 | 28 |
| Capital spending | 10 | 7 | 1 | 8 | 24 | 10 | 1 | — | 0 | 3 | 1 | 11 | 8 | 42 | 10 | 5 | 10 |
| Free cash flow | −158 | −131 | −120 | −137 | −20 | −68 | −79 | — | −38 | −91 | −29 | −73 | −88 | −8 | 33 | 14 | −18 |
| Free cash flow after stock pay | −172 | −142 | −134 | −182 | −69 | −76 | −84 | — | −45 | −97 | −35 | −85 | −102 | −26 | 11 | −11 | −46 |
| Shares issued | — | — | — | 50 | — | 28 | 1 | 1 | — | — | — | — | — | — | — | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 9 | 23 | −6 | 9 | 24 | −8 | −5 | −18 |
| Depreciation and amortisation | 2 | 2 | 2 | 2 | 2 | 6 | 6 | 2 |
| Stock-based pay | 5 | 6 | 5 | 8 | 4 | 7 | 6 | 10 |
| Capital spending | 1 | 3 | 0 | 1 | 1 | 2 | 2 | 5 |
| Free cash flow | 8 | 20 | −7 | 8 | 23 | −10 | −7 | −23 |
| Free cash flow after stock pay | 3 | 14 | −12 | 0 | 18 | −17 | −14 | −34 |
Compare with peers
- Meiragtx Holdings plc cash flow
- Sinovac Biotech LTD cash flow
- Pharming Group N.V. cash flow
- Novavax Inc cash flow
- Ardelyx, Inc. cash flow
Head to head: MGTX vs MNKDMNKD vs SVAMNKD vs PHARMNKD vs NVAX
More: Biotechnology stocks compared, Health Care sector, rankings of US companies